medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2010, Number 592

<< Back Next >>

Rev Med Cos Cen 2010; 67 (592)

Toxoplasmosis y embarazo

Azofeifa SR

Language: Spanish
References: 14
Page: 163-167
PDF size: 536.87 Kb.


ABSTRACT

Toxoplasmosis is a disease that is caused by infection with the protozoan T. gondii, primary infection in pregnant women, which is transmitted transplacentally, can cause congenital toxoplasmosis, pregnant women who acquire infection from T gondii usually remain asymptomatic, although they can still transmit the infection to their fetuses with severe consequences, the maternal diagnosis of toxoplasmosis during pregnancy is primarily made by the use of serological tests. Congenital toxoplasmosis is a preventable and treatable disease, treatment of acute toxoplasmosis during pregnancy may reduce but does not eliminate the risk of congenital infection. The use of Spiramycin during pregnancy in women who acquire acute T. gondii infection during gestation has been reported to decrease the frequency of vertical transmission, Spiramycin is indicated for pregnant women suspected to have or diagnosed with acute T. gondii infection acquired during the first trimester or early second trimester of gestation. The combination of Pyrimethamine, Sulfadiazine, and Folinic Acid is indicated for pregnant women suspected to have or diagnosed with acute T. gondii infection acquired late in the second trimester or during the third trimester of gestation. Monthly fetal ultrasounds are also recommended for women suspected or diagnosed as having acquired acute toxoplasmosis during pregnancy.


REFERENCES

  1. Boyer K., Holfels E., Roizen N.: “RISK FACTORS FOR TOXOPLASMA GONDII INFECTION IN MOTHERS OF INFANTS WITH CONGENITAL TOXOPLASMOSIS: IMPLICATIONS FOR PRENATAL MANAGEMENT AND SCREEN-ING”. AJOG (2005)192; 564-571

  2. Brunton L.; GOODMAN & GILMAN`S THE PHARMACOLOGICAL BASIS OF THERAPEUTICS.

  3. Chemotherapy of Protozoal Infections, McGraw-Hil. Ed XI (2006) CAP 40.

  4. Chin J.: EL CONTROL DE ENFER-MEDADES TRASMISIBLES. Toxo-plasmosis OPS,. Ed. XVII. (2001) 581; 624-628

  5. Cunningham E. G., Leveno K. J.: OBSTETRICIA DE WILLIAMS. Infecciones por Protozoarios.. Mc Graw Hill Ed. XXII (2006) 1289-1291.

  6. De Leon D., Botero L. F.: TEORIA Y NORMAS PARA EL MANEJO DE ENTIDADES GINECOOBSTE-TRICAS. Toxoplasmosis y Embarazo. Universidad Javariana. Colombia (1995)159-167

  7. Faro S, Soper D. E.: ENFERMEDADADES INFECCIOSAS EN LA MUJER. Ed. Mc Graw Hill,Capítulo III; 63-87

  8. Koppe J. G., Loewer-Sieger D. H., Roever-Bonnet H.: “RESULTS OF 20-YEAR FOLLOW-UP OF CONGENITAL TOXOLASMOSIS”. Lancet (1986) 254-256.

  9. Krevetz J. D., Federman D. G.: “TOXOPLASMOSIS IN PREG-NANCY”. The American Journal of Medicine (2005.)118; 212-216.

  10. MaCabe R. T., Reminton J. S.: “TOXOPLASMOSIS: THE TIME HAS GONE”. N.E. J. Medicine (1988) 313-315

  11. Mcphee S., Papadakis M.: Current Medical Diagnosis & Treatment. Infectious Diseases, Lange. Mc Graw Hill. 2008.

  12. Montoya J. G., Rosso F.: “DIAGNOSIS AND MANAGEMENT OF TOXOPLASMOSIS”.Clin Perinatol (2005)32; 705–726.

  13. Olaya C., Flores D.: “GUIA DE PRACTICA CLINICA PARA EL DIAGNOSTICO Y MANEJO DE LA TOXOPLASMOSIS GESTACIONAL”. Revista Colombiana Obstetricia y Ginecología, (2003) 54; 164-170

  14. OPS, ZOONOSIS Y ENFERMEDADES TRASMISIBLES COMUNES AL HOMBRE Y LOS ANIMALES. Parasitosis, Volumen III, (580) 89-98




2020     |     www.medigraphic.com